# A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®

> **NCT02968719** · PHASE1 · COMPLETED · sponsor: **Corium, Inc.** · enrollment: 107 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Donepezil TDS Version A
- **DRUG:** Donepezil TDS Version B
- **DRUG:** Aricept
- **DRUG:** Donepezil TDS Version D
- **DRUG:** Donepezil TDS Version E

## Key facts

- **NCT ID:** NCT02968719
- **Lead sponsor:** Corium, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-07-11
- **Final completion:** 2017-07-11
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02968719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02968719, "A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02968719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*